We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
SHORT-RANGE SECURE DATA COMMUNICATION METHOD BASED ON SOUND WAVE OR AUDIO, AND APPARATUS THEREOF
Composition for preventing or treating diabetes comprising nad glycohydrolase inhibitor as active ingredient
METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
METHOD, SYSTEM AND APPARATUS FOR IMPLEMENTING HYBRID NETWORKING OF MULTIPLE CLOCK SYNCHRONIZATION TECHNOLOGIES
CONTROL DEVICE AND CONTROL METHOD FOR REMOTELY-CONTROLLED TOY AIRPLANE
Composition comprising a meroterpen to manage oily skin with tendency to develop acne
CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES